Coeliac disease: A review of the causative agents and their possible mechanisms of action

Amino Acids

Volumn 10, Issue 1, 1996, Pages 1-19

  Cornell, H J ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Amino acids; Coeliac disease; Gliadin; Gluten sensitive enteropathy; Peptides; Wheat

Indexed keywords

GLUTEN; GLYCOPROTEIN; LECTIN; MEMBRANE PROTEIN;

CELIAC DISEASE; ENTEROPATHY; ENZYME DEFICIENCY; GASTROINTESTINAL TOXICITY; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; ORGAN CULTURE; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE;

TRITICUM AESTIVUM;

EID: 0030059401     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00806090     Document Type: Review

References (108)

1. Anderson CM, Frazer AC, French JM, Gerrard JW, Sammons HG, Smellie JM (1952) Coeliac disease: gastrointestinal studies and the effect of dietary wheat flour. Lancet i: 836-842
2. Andria G, Cucchiara S, De Vizia B, De Ritis G, Mazzacca G, Auricchio S (1980) Brush border and cytosol peptidase activities of human small intestine in normal subjects and coeliac patients. Pediatr Res 14: 812-818
3. Ashkenazi A, Idar D, Handzel ZT, Ofarim M (1978) An in-vitro immunological assay for diagnosis of coeliac disease. Lancet i: 627-629
4. Bernardin JE, Saunders RM, Kasarda DD (1976) Absence of carbohydrate in coeliac-toxic A-gliadin. Cereal Chem 53: 612-614
5. Bernardin JE, Kasarda DD, Mecham DK (1967) Preparation and characterisation of α-gliadin. J Biol Chem 242: 445-450
6. Bjarnason I, Peters TJ (1983) A persistent defect in small intestinal permeability in coeliac disease demonstrated by a 51-Cr-labelled EDTA absorption test. Lancet i: 323-325
7. Bjarnason I, Peters TJ (1984) In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. Gut 25: 145-150
8. Booth CC, Peters TJ, Doe WF (1977) Immunopathology of coeliac disease. In: Immunology of the gut. Ciba Foundation Symposium 46 (new series) Excerpta Medica, Amsterdam, pp 329-341
9. Bronstein HD, Haeffner LJ, Kowlessar OD (1966) Enzymatic digestion of gliadin: the effect of the resultant peptides in adult celiac disease. Clin Chim Acta 14: 141-155
10. Bürgin-Wolf A, Berger R, Gaze H, Huber H, Lentze MJ, Nussle D (1989) IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multi-centre study. Eur J Pediatr 148: 496-502
11. Ciclitira PJ, Evans DJ, Fagg NLK, Lennox ES, Dowling RH (1984) Clinical testing of gliadin fractions in coeliac patients. Clin Sci 66: 357-364
12. Cooke WT, Holmes GKT (1984) Clinical presentation. In: Coeliac disease. Churchill Livingstone, London, pp 81-105
13. Corazza GR, Tabacchi M, Frisoni M, Prati C, Gasbarrini G (1985) DR and non-DR Ia allotypes are associated with susceptibility in coeliac disease. Gut 26: 1210-1213
14. Cornell HJ (1974) Circulating antibodies to wheat gliadin fractions in coeliac disease. Arch Dis Childh 49: 454-458
15. Cornell HJ (1988) Amino acid composition of peptides remaining after mucosal digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease. Clin Chim Acta 176: 279-290
16. Cornell HJ, Maxwell RJ (1982) Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease. Clin Chim Acta 123: 311-319
17. Cornell HJ, Mothes T (1993) The activity of wheat gliadin peptides in in vitro assays for coeliac disease. Biochim Biophys Acta 1181: 169-173
18. Cornell HJ, Mothes T (1995) Further studies of the in vitro activity of synthetic gliadin peptides in coeliac disease. Biochim Biophys Acta (in press)
19. Cornell HJ, Townley RRW (1973a) Investigation of possible intestinal peptidase deficiency in coeliac disease. Clin Chim Acta 43: 113-125
20. Cornell HJ, Townley RRW (1973b) The effect of gliadin peptides on rat liver lysosomes in relation to the pathogenesis of coeliac disease. Clin Chim Acta 49: 181-188
21. Cornell HJ, Townley RRW (1974) The toxicity of certain cereal proteins in coeliac disease. Gut 15: 862-869
22. Cornell HJ, Auricchio RS, de Ritis G, de Vincenzi M, Maiuri L, Raia V, Silano V (1988) Intestinal mucosa of coeliac in remission is unable to abolish toxicity of gliadin peptides on in-vitro developing fetal rat intestine and cultured atrophic coeliac mucosa. Paediatr Res 24: 233-237
23. Cornell HJ, Wieser H, Belitz H-D (1992) Characterisation of the gliadin-derived peptides which are biologically active in coeliac disease. Clin Chim Acta 213: 37-50
24. Cornell HJ, Skerritt JH, Puy R, Javadpour M (1994) Studies of in vitro γ-interferon production in coeliac disease as a response to gliadin peptides. Biochim Biophys Acta 1226: 126-130
25. Cunningham-Rundles S, Cunningham-Rundles C, Pollack RA, Good RA, Dupont B (1978) Response to wheat antigen in in vitro lymphocyte transformation among HLA-B8-positive normal donors. Transplant Proc 10: 977-979
26. Davidson AGF, Bridges MA (1987) Coeliac disease: a critical review of the aetiology and pathogenesis. Clin Chim Acta 163: 1-46
27. De Marchi M, Borelli I, Olivetti E, Richiardi P, Wright P, Ansaldi N, Barbera C, Santini B (1979) Two HLA-D and DR alleles are associated with coeliac disease. Tissue Antigens 14: 309-316
28. De Ritis G, Occorsio P, Auricchio S, Gramenzi F, Morisi G, Silano V (1979) Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediat Res 13: 1255-1261
29. De Ritis G, Auricchio S, Jones HW, Lew EJ-L, Bernardin JE, Kasarda DD (1988) In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 94: 41-49
30. Devery JM, Bender V, Pentila I, Skerritt JH (1991) Identification of reactive synthetic gliadin peptides specific for coeliac disease. Int Arch Allergy Appl Immunol 95: 356-362
31. Dicke WK (1950) Coeliakie. MD Thesis, Utrecht
32. Doe WF, Booth CC, Brown DL (1973) Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease and ulcerative colitis. Lancet i: 402-403
33. Dolly JO, Fottrell PF (1969a) Multiple forms of dipeptidases in normal human intestinal mucosa and in mucosa from children with coeliac disease. Clin Chim Acta 26: 555-558
34. Dolly JO, Fottrell PF (1969b) Effect of different peptide fractions from wheat gliadin on rat liver lysosomes. Irish J Med Sci 2: 47
35. Douglas AP (1976) The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects. Clin Chim Acta 73: 357-361
36. Douglas AP, Peters TJ (1970) Peptide hydrolase activity of human intestinal mucosa in adult coeliac disease. Gut 11: 15-17
37. Egan-Mitchell B, Fottrell PF, McNicholl B (1978) Prolonged gluten tolerance in treated coeliac disease. In: McNicholl B, McCarthy CF, Fottrell PF (eds) Perspectives in coeliac disease. University Park Press, Baltimore, pp 251-257
38. Ellis HJ, Doyle AP, Wieser H, Sturgess RP, Ciclitira PJ (1992) Specificities of monoclonal antibodies raised against domain 1 of α-gliadin and their application in the measurement of gluten in foods. Report of 7th Meeting of Working Group on Prolamin Analysis and Toxicity. Schloss Weitenburg, Germany. Nov 4-6, 1992, p 19
39. Ezeoke A, Ferguson A, Fakhr O, Hekkens W Th JM, Hobbs JR (1974) Antibodies in the sera of coeliac patients which can coopt K-cells to attack gluten-labelled targets. In: Hekkens W Th JM, Peña As (eds) Coeliac disease. Proceedings of the 2nd International Coeliac Symposium, Stenfert Kroese, Leiden, pp 176-186
40. Fais S, Maiuri L, Pallone F, De Vincenzi M, De Ritis G, Troncone R, Auricchio S (1992) Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa. Gut 33: 472-475
41. Falchuk ZM, Strober W (1974) Gluten-sensitive enteropathy: synthesis of anti-gliadin antibody in vitro. Gut 15: 947-952
42. Falchuk ZM, Rogentine GN, Strober W (1972) Predominance of histocompatability antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest 51: 1602-1606
43. Falchuk ZM, Gebhard RL, Sessoms CS, Strober W (1974a) An in vitro model of gluten sensitive enteropathy. J Clin Invest 53: 487-500
44. Falchuk ZM, Gebhard RL, Strober W (1974b) The pathogenesis of gluten-sensitive enteropathy (coeliac-sprue): organ culture studies. In: Hekkens WTJM, Peña AS (eds) Coeliac disease. Stenfert Kroese, Leiden, pp 107-120
45. Ferguson A, Murray D (1971) Quantification of intra-epithelial lymphocytes in human jejunum. Gut 12: 988-994
46. Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P (1992) Endomysial antibody: is it the best screening test for coeliac disease? Gut 33: 1633-1637
47. Frazer AC, Fletcher RF, Ross CAC, Shaw B, Sammons HG, Schneider R (1959) Gluten induced enteropathy: the effect of partially digested gluten. Lancet ii: 252-255
48. Frew AJ, Bright S, Shewry PR, Munro A (1980) Proliferative response of lymphocytes of normal individuals to wheat proteins (gliadins). Int Arch Allergy Appl Immunol 62: 162-167
49. Friis S, Dabelsteen E, Sjöström H, Norén O, Jarnum S (1992) An increased uptake of gliadin fragments in the intestinal mucosa may be of central importance for the pathogenesis of coeliac disease. Poster abstract 23, International Coeliac Symposium, Dublin 1992, Scientific Program, p 33
50. Gee S (1888) On the coeliac affection. St. Bart Hosp Rep 24: 17-20
51. Gouzi J, Skerritt JH, Mitchell JD (1991) A reliable screening test for coeliac disease: enzyme-linked immunosorbent assay to detect anti-gliadin antibodies in serum. Aust NZJ Med 21: 723-731
52. Graf L, Horvath K, Walcz E, Berzetei I, Burnier J (1987) Effect of two synthetic α-gliadin peptides on lymphocytes in celiac disease: identification of a novel class of opioid receptors. Neuropeptides 9: 113-122
53. Hamilton I, Cobden I, Rothwell J, Axon ATR (1982) Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut 23: 202-210
54. Harris OD, Cooke WT, Thompson H, Waterhouse JAH (1967) Malignancy in adult coeliac disease and idiopathic steatorrhoea. Am J Med 42: 899-912
55. Hekkens W Th JM, Haex AI Ch, Willighagen RGI (1970) Some aspects of gliadin fractionation and testing by a histochemical method. In: Booth CC, Dowling RH (eds) Coeliac disease. Churchill Livingstone, Edinburgh, pp 11-19
56. Holmes GKT, Prior P, Lane MR, Pope D, Allan RN (1989) Malignancy in coeliac disease - effect of a gluten-free diet. Gut 30: 333-338
57. Hudson DA, Purdham DR, Cornell HJ, Rolles CJ (1976) Non-specific cytotoxicity of wheat gliadin components towards cultured human cells. Lancet 1: 339-341
58. Jos J, Lenoir G, De Ritis G, Rey J (1975) In vitro pathogenetic studies of coeliac disease: effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours. Scand J Gastroenterol 10: 121-128
59. Jos J, Charbonnier L, Mosse J, Olives JP, De Tand M-F, Rey J (1982) The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography on Biogel P-10. Clin Chim Acta 119: 263-274
60. Kasarda DD (1978) The relationship of wheat proteins to celiac disease. Cereal Foods World 23: 240-245
61. Kasarda DD, Okita TW, Bernardin JE, Baecker PA, Nimmo CC, Lew EJL, Dietler MD, Greene FC (1984) Nucleic acid (cDNA) and amino acid sequenes of α-type of gliadins from wheat (Triticum aestivum). Proc Natl Acad Soc USA 81: 4712-4716
62. Kendall MJ, Cox PS, Schneider R, Hawkins CF (1972) Gluten sub-fractions in coeliac disease. Lancet ii: 1065-1067
63. Kenrick KG, Walker-Smith JA (1970) Immunoglobulins and dietary protein antibodies in childhood coeliac disease. Gut 11: 635-640
64. Kocna P, Mothes T, Krchnak V, Fric P (1991) Relationship between gliadin peptide structure and their effects on the fetal chick duodenum. Z Lebensm Unters Forsch 192: 116-119
65. Kottgen E, Kluge F, Volk B, Gerok W (1983) The lectin properties of gluten as the basis of the pathomechanism of gluten-sensitive enteropathy. Klin Wochenschr 61:111-112
66. Lifshitz F, Fagundes-Neto U (1983) The malabsorption syndrome. In: Silverberg M (ed) Paediatric gastroenterology. Medical Examination Publishing Co., Inc., New York, pp 315-321
67. Lindberg T, Norden A, Josefsson L (1968) Intestinal dipeptidases: dipeptidases activities in small intestinal biopsy specimens from a clinical material. Scand J Gastroenterol 3: 177-182
68. Lorenzsonn V, Olsen WA (1982) In vivo responses of rat intestinal epithelium to intraluminal dietary lectins. Gastroenterology 82: 838-848
69. McDonald WC, Dobbins WO, Rubin CE (1965) Studies of the familiar nature of celiac sprue using biopsy of the small intestine. N Engl J Med 172: 448-456
70. McNeish AS, Harms HK, Rey J, Shmerling DH, Visakorpi JK, Walker-Smith JA (1979) The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 54: 783-786
71. Maiuri L, Picarelli A, Fais S, Boirivant M, Burgio V, Coletta S, Auricchio S (1994) Gliadin peptides induce recruitment of mononuclear cells to the surface epithelium and overexpression of ICAM 1 and ICAM 3 molecules in cultured treated celiac mucosa. J Pediatr Gastroenterol Nutr 19: 331
72. Mäki M, Hällström O, Marttinen (1991) Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies. Lancet ii: 724-725
73. Mantzaris G, Jewell DP (1991) In vivo toxicity of a synthetic dodecapeptide from A-gliadin in patients with coeliac disease. Scand J Gastroenterol 26: 392-398
74. Marsh MN (1981) The small intestine: mechanisms of local immunity and gluten sensitivity. Clin Sci 61: 497-503
75. Messer M, Anderson CM, Hubbard L (1964) Studies on the mechanism of destruction of the toxic action of wheat gluten in coeliac disease by crude papain. Gut 5: 295-303
76. Mothes T, Muhle W, Müller F, Hekkens WTJM (1985) Influence of gliadin on fetal chick intestine in tissue culture. Biol Neonate 48: 59-64
77. Mothes T, Bendix U, Pfannschmidt C, Lehmann I (1995) Effect of gliadin and other food peptides on the expression of MHC Class II molecules by HT29 cells. Gut (in press)
78. Mowat A McI (1989) Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus host reaction. Immunolgy 68: 18-23
79. Penttila IA, Devery JM, Gibson CE, LaBrooy JT, Skerritt JH (1991) Cellular and humoral responses in coeliac disease. 1. Wheat protein fractions. Clin Chim Acta 204: 95-108
80. Peters TJ, Bjarnason I (1984) Coeliac syndrome: biochemical mechamism and the missing peptidase hypothesis revisited. Gut 25: 913-918
81. Peters TJ, Jones PE, Wells G (1978a) Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to gluten withdrawal in patients with coeliac disease. Clin Sci Molec Med 55: 285-292
82. Peters TJ, Jones PE, Jenkins WJ, Wells G (1978b) Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to corticosteroids in patients with non-responsive coeliac disease. Clin Sci Molec Med 55: 293-300
83. Phelan JJ, Stevens FM, McNicholl B, Fottrell PF, McCarthy CF (1977) Coeliac disease: the abolition of gliadin toxicity by enzymes from Aspergillus niger. Clin Sci Molec Med 53: 35-43
84. Polanco I, Biermond I, Van Leeuwen A, Schreuder I, Khan MP, Guerrero J, D'Amaro J, Vasquez C, Van Rood JJ, Pena AS (1981) Gluten sensitive enteropathy in Spain: genetic and environmental factors. In: McConnell RB (ed) The genetics of coeliac disease. MTP press, Lancaster, pp 211-231
85. Rocca E, Paganuzzi-Stammati A, Zampaglioni F, Zucco F (1983) Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis. Toxicol Let 16: 331-338
86. Rolles CJ, Kyaw Myint TO, Wai-Kee S, Anderson CM (1974) Family study of coeliac disease. Gut 15: 827
87. Sachs JA, Awad J, McCloskey D, Navarrete C, Festenstein H, Elliot E, Walker-Smith JA, Griffiths CEM, Leonard JN, Fry L (1986) Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis. Gut 27: 515-520
88. Scott BB, Losowsky MS (1976) Cell mediated autoimmunity in coeliac disease. Clin Exp Immunol 26: 243-246
89. Seah PP, Fry L, Rossiter MA, Hoffbrand AV, Holborrow EJ (1971) Anti-reticulin antibodies in childhood coeliac disease. Lancet ii: 681-682
90. Sheldon W (1969) Prognosis in early adult life of coeliac children treated with a gluten-free diet. Br Med J 2: 401-404
91. Shiner M (1959) Small intestinal biopsy: diagnostic and research value. Proc R Soc Med 52: 10-14
92. Shiner M, Ballard J (1972) Antigen-antibody reactions in jejunal mucosa in childhood coeliac disease after gluten challenge. Lancet i: 1202-1205
93. Shmerling DH, Shiner M (1970) The response of the intestinal mucosa to the intraduodenal instillation of gluten in patients with coeliac disease during remission. In: Booth CC, Dowling RH (eds) Coeliac disease. Churchill Livingstone, Edinburgh, pp 64-74
94. Sikora K, Anand BS, Truelove SC, Ciclitira PJ, Offord RE (1976) Stimulation of lymphocytes from patients with coeliac disease by a sub-fraction of gluten. Lancet ii: 389-391
95. Simpson FG, Howdle PD, Robertson DAF, Losowsky MS (1983) Jejunal biopsy and lymphocyte co-culture in coeliac disease. Scand J Gastroenterol 18: 749-754
96. Sjostrom H, Noren O, Krasilnikoff PA (1981) Gudmand-Hoyer E. Intestinal peptidases and sucrase in coeliac disease. Clin Chim Acta 109: 53-58
97. Skerritt JH, Devery JM, Penttila IA, La Brooy JT (1991) Cellular and humoral responses in coeliac disease. 2. Protein extracts from different cereals. Clin Chim Acta 204: 109-122
98. Strober W (1976) Gluten-sensitive enteropathy. Clin Gastroenterol 5: 429-452
99. Sturgess R, Day P, Ellis HJ, Lundin KEA, Gjertsen HA, Kontakov M, Ciclitira PJ (1994) Wheat peptide challenge in coeliac disease. Lancet 343: 758-761
100. Townley RRW. Cornell HJ, Bhathal PS, Mitchell JD (1973) Toxicity of wheat gliadin fractions in coeliac disease. Lancet i: 1363-1364
101. Troncone R (1992) Identification of toxic and/or immunogenic gliadin peptides. Report of 7th Meeting of Working Group on Prolamin Analysis and Toxicity, Schloss Weitenburg, Germany, Nov 4-6, 1992, pp 39-42
102. Van de Kamer JH, Weijers HA (1955) Coeliac disease V: some experiments on the cause of the harmful effect of wheat gliadin. Acta Paediatr 44: 465-469
103. Van de Kamer JH, Weijers HA, Dicke WK (1953) An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease. Acta Paediatr 42: 223-231
104. Weiser MM, Douglas AP (1976) An alternative mechanism for gluten toxicity in coeliac disease. Lancet i: 567-569
105. Wieser H, Belitz HD, Ashkenazi A (1984) Amino acid sequence of the coeliac active peptide B 3142. Z Lebensm Unters Forsch 179: 371-376
106. Wieser H, Belitz H-D, Idar D, Ashkenazi A (1986) Coeliac activity of the gliadin peptides CT-1, and CT-2. Z Lebensm Unters Forsch 182: 115-117
107. Woychik AC, Boundy JA, Dimler RJ (1961) Starch-gel electrophoresis of wheat gluten proteins with concentrated urea. Arch Biochem Biophys 94: 477-482
108. Wrigley CW, Shepherd KW (1973) Electrofocussing of grain proteins from wheat genotypes. Ann NY Acad Sci 209: 154-162